|
|
|
|
News
|
|
China Earthquake Donation
|
|
Please use encoding Chinese Simplified (GB2312) to view the following news.
四川大地震已经造成逾万的死亡，伤者无数。CABS呼吁广大海外留学人员和华人华侨捐款支援灾区。
1) CABS is a 501(c)(3) 非营利组织，如您在美国捐款，您可以减税。
Donations of individuals or corporations through CABS are tax-deductible. CABS will send you a donation receipt. And CABS will pass 100% of your donation to China Red Cross. Please send your check to: (note on check - earthquake donation)
CABS
...
|
|
|
|
Drug makers stick by China
Life sciences companies establishing roots despite contamination trouble
|
|
By Todd Wallack/March 14, 2008
At the same time medical imports from China are raising safety concerns worldwide, some local life sciences companies are expanding manufacturing operations there.
Atleast 19 people have died from allergic reactions linked to contaminated shipments of heparin, a blood thinner, imported from China, according to the Food and Drug Administration. In Panama last year, dozens of deaths were traced to Chinese-made medicine tainted with an ingredient found
...
|
|
|
|
WuXi PharmaTech, In China, For World
|
|
On January 31, 2008, WuXi PharmaTech., China's largest drug research contractor, announced the completion of its acquisition of AppTec Laboratory Services, Inc., a U.S.-based service provider for biopharmaceutical and medical device industries with three facilities in St. Paul, Philadelphia, and Atlanta. The transaction consideration totals approximately $151 million with the assumption of AppTec debt totaling approximately $11.7 million. The combined business will enable WuXi PharmaTech to pr
...
|
|
|
|
Cloning Said to Yield Human Embryos By ANDREW POLLACK (January 18, 2008)
|
|
Scientists at a small biotechnology company say they have used cloning to create human embryos from the skin cells of two men.
The work represents a step toward the promise of creating personalized embryonic stem cells that could be used for medical treatments. Although the embryos grew only to a very early stage, the work could also theoretically be seen as a step toward creating babies that are genetic copies of other people.
Scientists at the company, Stemagen, which is based i
...
|
|
|
|
New Study Confirms Innovative Therapies Will Have Minimal Impact on Healthcare Costs
|
WASHINGTON, D.C. (April 10, 2007) -- The widening use of new, innovative biopharmaceutical treatments for diseases, such as cancer, multiple sclerosis and heart disease, will have a limited impact on healthcare costs for private healthcare payers over the next several years, according to an independent study released today by the Biotechnology Industry Organization (BIO).
This well-researched analysis by one of the world most respected healthcare actuarial firms is good news for millions
...
|
|
|
|
|
|
